My HPRA: Register

KEYTRUDA

25 Mg/Ml Concentrate for Soln for Inf

Merck Sharp & Dohme LtdEU/1/15/1024/002

Main Information

Trade NameKEYTRUDA
Active SubstancesPEMBROLIZUMAB
Strength25 Mg/Ml
Dosage FormConcentrate for Soln for Inf
Licence HolderMerck Sharp & Dohme Ltd
Licence NumberEU/1/15/1024/002

Group Information

ATC CodeL01XC18 pembrolizumab

Status

Authorised/WithdrawnAuthorised
Licence Issued18/08/2016
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print